Literature DB >> 4013141

Blood donors positive for HBsAg and negative for anti-HBc antibody.

A M Couroucé, J Drouet, N LeMarrec, A Drouet, J P Soulier.   

Abstract

From January 1980 to December 1983, 989,907 blood donations were screened for HBsAg. A total of 1,345 was found HBsAg positive; 33 of whom were negative for anti-HBc (2.45%); in 10 cases HBeAg was present at a low level along with HBsAg. 2 of the 33 subjects were lost to follow-up. Late serum samples were available for 28 blood donors, and clinical and biological data only were known for the 3 others. An evolution of HBV markers was observed in each case; anti-HBc antibody became positive in 24 subjects (the 4 remaining subjects had a very short follow-up); HBeAg was positive at a high titer in 18 subjects and seroconversion to anti-HBe was observed in 7 individuals; HBsAg concentration increased in 21 subjects from 2 to 4,000 times and decreased in the 7 others. Seroconversion to anti-HBs was observed in 8 individuals. According to these serological, biological and clinical findings, different outcomes were observed: in 6 subjects too short a follow-up was available to allow appropriate classification, but there was evidence to suggest all probably developed clinical hepatitis; in 6 subjects asymptomatic hepatitis with rapid loss of HBsAg occurred; in 2 subjects asymptomatic hepatitis with the persistence of HBsAg at a low level and seroconversion to anti-HBe occurred; and in 17 subjects clinical hepatitis developed. These observations establish that most of the 33 blood donors were infectious at the time of their blood donation, and that anti-HBc antibody screening must not replace HBsAg screening for blood donations.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4013141     DOI: 10.1111/j.1423-0410.1985.tb00764.x

Source DB:  PubMed          Journal:  Vox Sang        ISSN: 0042-9007            Impact factor:   2.144


  6 in total

1.  Hepatitis B core antibody-negative HBsAg carriers.

Authors:  R Vranckx; L Muylle; A Meheus
Journal:  Infection       Date:  1989 Jul-Aug       Impact factor: 3.553

2.  Type 2 hepatitis B virus (HBV-2) in carriers and patients with malignancy in Saudi Arabia.

Authors:  S C Arya; V P Pathak; S J Ashraf
Journal:  Infection       Date:  1990 Jul-Aug       Impact factor: 3.553

3.  Clinical significance of low or negative titer of antibody to hepatitis B core antigen during the course of chronic hepatitis B virus infection in adolescents.

Authors:  K Matsuura; K Tobe; Y Iwasaki; H Ikeda; K Takahashi; T Tsuji
Journal:  Gastroenterol Jpn       Date:  1993-02

4.  Anti-HBc screening for the prevention of perinatal transmission of hepatitis B virus in France.

Authors:  B Descos; J Scotto; V Fayol; J Y Huet; C Pichoud; M Hermier; G Ville; F Charvet; D Dargent; J M Thoulon
Journal:  Infection       Date:  1987 Nov-Dec       Impact factor: 3.553

5.  Clinical Characteristics and Correlation Analysis of Subjects with Chronic Hepatitis B Virus (HBV) Infection and Sustained Low Levels of Hepatitis B Surface Antigen (HBsAg).

Authors:  Jun Cheng; Yuzhu Dai; Li Yan; Huajun Zhou; Xujian Xu; Changgui Sun; Zhongyong Wang
Journal:  Med Sci Monit       Date:  2018-03-29

6.  Clinical characteristics and association analysis of persistent low-level HBsAg expression in a physical examination population with HBV infection.

Authors:  Yuzhu Dai; Feihu Che; Xiaoxiao Jiang; Dawei Cui; Huajun Zhou; Xujian Xu; Changgui Sun; Jun Cheng
Journal:  Exp Ther Med       Date:  2019-11-19       Impact factor: 2.447

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.